glp 1 and osteoporosis AAOS: GLP-1 receptor agonist use increases five-year risk for Frontiers | Effect of gut
Description
The GLP-1 Analogues Market estimated size and share is projected to exceed USD 322.85 Billion by 2034, with a forecasted CAGR of 21.3% during the period.
The real problem seems to be retention
Note: Anti-Obesity GLP-1s Wegovy and Zepbound, Anti-Diabetes GLP-1s Ozempic and Mounjaro Source: IQVIA MAAS Patient Behavior Library Tool
Evolv | 1,544 followers on LinkedIn
60-Day Guarantee: Includes a 60-day money-back guarantee
